The company opened a division in Moscow operating in the Russian Federation and the Central Asian republics. It also established a branch in Ukraine.

Polpharma established the Foundation for the Development of Polish Pharmacy and Medicine, which annually announces a competition for the best research projects.

The first Etopiryna commercial appeared on TV. Since that time, this drug for headache has inevitably been associated with Ms Gozdzikowa, a well-known commercial actress.

A Trade Office was established in Warsaw, with dynamic and modern marketing and sales structures. The Office is located at ul. Sapiezynska.

In December, Polpharma launched its new branding.

Polscreen, a National Coronary Heart Disease Prevention Program, began. It was the largest global population-based study, developed by the Prevention Committee of the Polish Cardiac Society, financed by a research

Polpharma implemented a coherent and modern visual identification for packages of prescription drugs.

Polpharma opened a modern building for the Research and Development Centre and Quality Control Laboratory. The facility meets the requirements of Good Laboratory Practice (GLP). It is one of the

The company opened another facility a Logistics Centre. The building complies with the requirements of Good Distribution Practice (GDP) for the storage of pharmaceutical products.

The company started operation of a new ampoule production facility. Its annual production capacity amounts to 50 million glass ampoules. The property was designed and built in accordance with cGMP

Polpharma opened a new training and administration centre in Starogard Gdanski, which significantly expanded the company’s capabilities relating to the organisation of training sessions and meetings with clients and guests.

Polpharma established an independent affiliated company in Belarus. Previously, the division in Lithuania was responsible for this country.

Polpharma began strategic cooperation with Akrikhin - one of the largest pharmaceutical companies in Russia.

Polpharma received ISO 14001 environmental certificate and an OHSAS 18001 occupational health and safety certificate.

Two new affiliated companies are established - in Azerbaijan and Uzbekistan.

Polpharma passed an inspection by the Food and Drug Administration (FDA). As a result, APIS manufactured by the company gained access to the highly developed US market.

Polpharma acquires the antibiotics portfolio and the Production Plant in Duchnice from Bioton.